139 related articles for article (PubMed ID: 11816709)
41. Prognosis in human melanoma: PAR-1 expression is superior to other coagulation components and VEGF.
Depasquale I; Thompson WD
Histopathology; 2008 Mar; 52(4):500-9. PubMed ID: 18315603
[TBL] [Abstract][Full Text] [Related]
42. Expression of tissue factor mRNA and invasion of blood vessels by tumor cells in non-small cell lung cancer.
Minamiya Y; Matsuzaki I; Sageshima M; Saito H; Taguchi K; Nakagawa T; Ogawa J
Surg Today; 2004; 34(1):1-5. PubMed ID: 14714220
[TBL] [Abstract][Full Text] [Related]
43. Correlation of protease-activated receptor-1 with differentiation markers in squamous cell carcinoma of the head and neck and its implication in lymph node metastasis.
Zhang X; Hunt JL; Landsittel DP; Muller S; Adler-Storthz K; Ferris RL; Shin DM; Chen ZG
Clin Cancer Res; 2004 Dec; 10(24):8451-9. PubMed ID: 15625067
[TBL] [Abstract][Full Text] [Related]
44. Deencryption of cellular tissue factor is independent of its cytoplasmic domain.
Wolberg AS; Kon RH; Monroe DM; Ezban M; Roberts HR; Hoffman M
Biochem Biophys Res Commun; 2000 Jun; 272(2):332-6. PubMed ID: 10833414
[TBL] [Abstract][Full Text] [Related]
45. Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model.
Song X; Wang B; Bromberg M; Hu Z; Konigsberg W; Garen A
Proc Natl Acad Sci U S A; 2002 Apr; 99(9):6269-73. PubMed ID: 11959915
[TBL] [Abstract][Full Text] [Related]
46. Expression of tissue factor by melanoma cells promotes efficient hematogenous metastasis.
Mueller BM; Reisfeld RA; Edgington TS; Ruf W
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):11832-6. PubMed ID: 1465406
[TBL] [Abstract][Full Text] [Related]
47. Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
López-Pedrera C; Barbarroja N; Dorado G; Siendones E; Velasco F
Leukemia; 2006 Aug; 20(8):1331-40. PubMed ID: 16728982
[TBL] [Abstract][Full Text] [Related]
48. Molecular regulation of blood clotting in tumor biology.
Ruf W
Haemostasis; 2001; 31 Suppl 1():5-7. PubMed ID: 11990479
[TBL] [Abstract][Full Text] [Related]
49. Orchestration of coagulation protease signaling by tissue factor.
Riewald M; Ruf W
Trends Cardiovasc Med; 2002 May; 12(4):149-54. PubMed ID: 12069753
[TBL] [Abstract][Full Text] [Related]
50. Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis.
Wojtukiewicz MZ; Hempel D; Sierko E; Tucker SC; Honn KV
Cancer Metastasis Rev; 2015 Dec; 34(4):775-96. PubMed ID: 26573921
[TBL] [Abstract][Full Text] [Related]
51. Protease-activated receptor 2-dependent phosphorylation of the tissue factor cytoplasmic domain.
Ahamed J; Ruf W
J Biol Chem; 2004 May; 279(22):23038-44. PubMed ID: 15039423
[TBL] [Abstract][Full Text] [Related]
52. Tissue factor and PAR1 promote microbiota-induced intestinal vascular remodelling.
Reinhardt C; Bergentall M; Greiner TU; Schaffner F; Ostergren-Lundén G; Petersen LC; Ruf W; Bäckhed F
Nature; 2012 Mar; 483(7391):627-31. PubMed ID: 22407318
[TBL] [Abstract][Full Text] [Related]
53. Protease-activated receptor 1 (PAR-1) is required and rate-limiting for thrombin-enhanced experimental pulmonary metastasis.
Nierodzik ML; Chen K; Takeshita K; Li JJ; Huang YQ; Feng XS; D'Andrea MR; Andrade-Gordon P; Karpatkin S
Blood; 1998 Nov; 92(10):3694-700. PubMed ID: 9808563
[TBL] [Abstract][Full Text] [Related]
54. Hemoglobin enhances tissue factor expression on human malignant cells.
Siddiqui FA; Amirkhosravi A; Amaya M; Meyer T; Biggerstaff J; Desai H; Francis JL
Blood Coagul Fibrinolysis; 2001 Apr; 12(3):171-7. PubMed ID: 11414630
[TBL] [Abstract][Full Text] [Related]
55. Expression of tissue factor signaling pathway elements correlates with the production of vascular endothelial growth factor and interleukin-8 in human astrocytoma patients.
Carneiro-Lobo TC; Lima MT; Mariano-Oliveira A; Dutra-Oliveira A; Oba-Shinjo SM; Marie SK; Sogayar MC; Monteiro RQ
Oncol Rep; 2014 Feb; 31(2):679-86. PubMed ID: 24297570
[TBL] [Abstract][Full Text] [Related]
56. High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors.
Koizume S; Ito S; Yoshioka Y; Kanayama T; Nakamura Y; Yoshihara M; Yamada R; Ochiya T; Ruf W; Miyagi E; Hirahara F; Miyagi Y
Thromb Haemost; 2016 Jan; 115(2):299-310. PubMed ID: 26446354
[TBL] [Abstract][Full Text] [Related]
57. Tumor cell invasion is promoted by activation of protease activated receptor-1 in cooperation with the alpha vbeta 5 integrin.
Even-Ram SC; Maoz M; Pokroy E; Reich R; Katz BZ; Gutwein P; Altevogt P; Bar-Shavit R
J Biol Chem; 2001 Apr; 276(14):10952-62. PubMed ID: 11278329
[TBL] [Abstract][Full Text] [Related]
58. Protease activated receptor-1 inhibits the Maspin tumor-suppressor gene to determine the melanoma metastatic phenotype.
Villares GJ; Zigler M; Dobroff AS; Wang H; Song R; Melnikova VO; Huang L; Braeuer RR; Bar-Eli M
Proc Natl Acad Sci U S A; 2011 Jan; 108(2):626-31. PubMed ID: 21187389
[TBL] [Abstract][Full Text] [Related]
59. Targeting melanoma growth and metastasis with systemic delivery of liposome-incorporated protease-activated receptor-1 small interfering RNA.
Villares GJ; Zigler M; Wang H; Melnikova VO; Wu H; Friedman R; Leslie MC; Vivas-Mejia PE; Lopez-Berestein G; Sood AK; Bar-Eli M
Cancer Res; 2008 Nov; 68(21):9078-86. PubMed ID: 18974154
[TBL] [Abstract][Full Text] [Related]
60. Increased expression of tissue factor and protease-activated receptor-1 does not correlate with thrombosis in human lung adenocarcinoma.
de Meis E; Azambuja D; Ayres-Silva JP; Zamboni M; Pinheiro VR; Levy RA; Monteiro RQ
Braz J Med Biol Res; 2010 Apr; 43(4):403-8. PubMed ID: 20445954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
